COL10A1 is a novel factor in the development of choroidal neovascularization

Microvasc Res. 2022 Jan:139:104239. doi: 10.1016/j.mvr.2021.104239. Epub 2021 Sep 11.

Abstract

With the dramatic rise in the aging population, researching age-related macular degeneration (AMD), especially the severe form neovascular AMD (nAMD), has become more important than ever. In this study, we found that collagen type X was increased in retina-choroid tissue of mice with laser-induced choroidal neovascularization (CNV) based on immunohistofluorescence. RNA sequencing and bioinformatic analyses were performed to compare the retina-choroid tissue complex of the CNV mouse model to normal controls. Collagen type X alpha 1 chain (Col10a1) was among the most significantly upregulated genes, and the results were validated with an animal model at the mRNA and protein levels by quantitative real-time polymerase chain reaction (qPCR) and western blotting, respectively. COL10A1 was also upregulated in human retinal microvascular endothelial cells (HRMECs), human umbilical vein endothelial cells (HUVECs), RPE19 cells and RF/6A cells under hypoxic conditions. Next, in vitro and in vivo experiments were performed to study the effect of COL10A1 on neovascularization. siRNA knockdown of COL10A1 suppressed the proliferation and tube formation ability of HRMECs under hypoxic conditions. Snail family transcriptional repressor 1 (SNAIL1) and angiopoietin-2 (ANGPT2) were downregulated in COL10A1 knockdown HRMECs under hypoxic conditions and thus were potential downstream genes. Significant decreases in CNV leakage and CNV lesion area, as assessed by fundus fluorescein angiography (FFA) and immunofluorescence of choroidal flat mounts, respectively, were observed in a mouse model intravitreally injected with anti-collagen X monoclonal antibody (mAb) compared to the controls. In conclusion, COL10A1 promotes CNV formation and may represent a new candidate target for the treatment and diagnosis of nAMD and other neovascular diseases.

Keywords: Age-related macular degeneration (AMD); COL10A1; Choroidal neovascularization (CNV); Hypoxia; RNA-sequence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiopoietin-2 / metabolism
  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Cell Hypoxia
  • Cell Line
  • Choroid / blood supply*
  • Choroidal Neovascularization / genetics
  • Choroidal Neovascularization / metabolism*
  • Choroidal Neovascularization / pathology
  • Choroidal Neovascularization / prevention & control
  • Collagen Type X / antagonists & inhibitors
  • Collagen Type X / genetics
  • Collagen Type X / immunology
  • Collagen Type X / metabolism*
  • Disease Models, Animal
  • Endothelial Cells / metabolism*
  • Endothelial Cells / pathology
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Human Umbilical Vein Endothelial Cells / pathology
  • Humans
  • Macular Degeneration / genetics
  • Macular Degeneration / metabolism*
  • Macular Degeneration / pathology
  • Macular Degeneration / prevention & control
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neovascularization, Physiologic* / drug effects
  • Signal Transduction
  • Snail Family Transcription Factors / metabolism

Substances

  • ANGPT2 protein, human
  • Angiopoietin-2
  • Antibodies, Monoclonal
  • COL10A1 protein, human
  • Col10a1 protein, mouse
  • Collagen Type X
  • SNAI1 protein, human
  • Snail Family Transcription Factors